#172 Biologically Similar but Competitively Not So? Economic Considerations of IP Litigation Settlements Involving Biosimilars Posted 1 year ago Tagged analysis antitrust biologics biosimilars competition economics generics intellectual property law litigation market payment pharmaceutical settlement Under the U.S. Supreme Court case FTC v. Actavis (2013), antitrust analysis of “reverse settlements” […] https://ourcuriousamalgam.com/episode-player/2256/172-biosimilars-ip-litigation-settlements.mp3?stats-code=ocaPodcastSite
